Latest Drugs Stories
MANNHEIM, Germany, March 23, 2015 /PRNewswire-iReach/ -- The Biosimilars Group offers as a new and unique service to its clients - a one-day workshop for full biosimilar development project
Timely survey released as FDA approves first biosimilar WASHINGTON, March 23, 2015 /PRNewswire/ -- The Alliance for Safe
In a March 31 webinar, three veteran pharmacy observers will detail steps payers can take now to develop effective biosimilars management strategies. Washington,
LONDON, March 17, 2015 /PRNewswire/ -- Report DetailsBiosimilar therapeutic antibodies - see why originator companies should now fear those competitors, discovering their trends
LONDON, March 17, 2015 /PRNewswire/ -- Report DetailsWorld OTC pharmaceuticals - your guide to technologies, trends and revenuesWhere is the world OTC pharmaceutical market
Those in households with children are willing to pay higher out-of-pocket expenses for generic prescription drugs NEW YORK, March 17, 2015 /PRNewswire/ -- A new Harris Poll finds Americans
WASHINGTON, March 13, 2015 /PRNewswire-USNewswire/ -- Every day patients around the world are living healthier, more productive lives thanks to innovative medicines developed by biopharmaceutical companies.
The new mobile app from EasyDrugCard.com extends the reach of the pharmacy discount program to uninsured and under-insured mobile users. Castle Rock, Colorado
S.B. 5857 Could Increase Rx Costs for Medicaid, State Employee Plan by up to $113 Million Annually Washington D.C.
According to the new report from BCC Research, the global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.